One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report

Second-generation antipsychotics, despite being highly effective, are among the drugs known to cause insulin resistance and metabolic syndrome, eventually leading to diabetes mellitus and less commonly diabetic ketoacidosis (DKA). Here, we present the case of a 21-year-old male, who was not previous...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammed Zain Ulabedin Adhoni, Roomiyah Riyaz Assadi, Saira Abbas
Formato:	article
Lenguaje:	EN
Publicado:	Karger Publishers 2021
Materias:	olanzapine diabetic ketoacidosis antipsychotics metabolic syndrome schizophrenia diabetes mellitus Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/46ac6e38b94240069ad42a7546ef8bc7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:46ac6e38b94240069ad42a7546ef8bc7
record_format	dspace
spelling	oai:doaj.org-article:46ac6e38b94240069ad42a7546ef8bc72021-11-11T10:40:46ZOne-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report2673-17972673-173810.1159/000519726https://doaj.org/article/46ac6e38b94240069ad42a7546ef8bc72021-10-01T00:00:00Zhttps://www.karger.com/Article/FullText/519726https://doaj.org/toc/2673-1797https://doaj.org/toc/2673-1738Second-generation antipsychotics, despite being highly effective, are among the drugs known to cause insulin resistance and metabolic syndrome, eventually leading to diabetes mellitus and less commonly diabetic ketoacidosis (DKA). Here, we present the case of a 21-year-old male, who was not previously known to have any comorbid factors but presented with DKA 1 year and 9 months after beginning treatment with olanzapine for an unspecified psychotic disorder requiring hospital admission and the resolution of the same following discontinuation of the drug. Our case report emphasizes the need for regular screening of patients requiring diabetogenic drugs, so that early identification of possible side effects can be noted and averted.Mohammed Zain Ulabedin AdhoniRoomiyah Riyaz AssadiSaira AbbasKarger Publishersarticleolanzapinediabetic ketoacidosisantipsychoticsmetabolic syndromeschizophreniadiabetes mellitusDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENDubai Diabetes and Endocrinology Journal, Pp 1-4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	olanzapine diabetic ketoacidosis antipsychotics metabolic syndrome schizophrenia diabetes mellitus Diseases of the endocrine glands. Clinical endocrinology RC648-665
spellingShingle	olanzapine diabetic ketoacidosis antipsychotics metabolic syndrome schizophrenia diabetes mellitus Diseases of the endocrine glands. Clinical endocrinology RC648-665 Mohammed Zain Ulabedin Adhoni Roomiyah Riyaz Assadi Saira Abbas One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
description	Second-generation antipsychotics, despite being highly effective, are among the drugs known to cause insulin resistance and metabolic syndrome, eventually leading to diabetes mellitus and less commonly diabetic ketoacidosis (DKA). Here, we present the case of a 21-year-old male, who was not previously known to have any comorbid factors but presented with DKA 1 year and 9 months after beginning treatment with olanzapine for an unspecified psychotic disorder requiring hospital admission and the resolution of the same following discontinuation of the drug. Our case report emphasizes the need for regular screening of patients requiring diabetogenic drugs, so that early identification of possible side effects can be noted and averted.
format	article
author	Mohammed Zain Ulabedin Adhoni Roomiyah Riyaz Assadi Saira Abbas
author_facet	Mohammed Zain Ulabedin Adhoni Roomiyah Riyaz Assadi Saira Abbas
author_sort	Mohammed Zain Ulabedin Adhoni
title	One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
title_short	One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
title_full	One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
title_fullStr	One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
title_full_unstemmed	One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
title_sort	one-year course of olanzapine-induced diabetic ketoacidosis: a case report
publisher	Karger Publishers
publishDate	2021
url	https://doaj.org/article/46ac6e38b94240069ad42a7546ef8bc7
work_keys_str_mv	AT mohammedzainulabedinadhoni oneyearcourseofolanzapineinduceddiabeticketoacidosisacasereport AT roomiyahriyazassadi oneyearcourseofolanzapineinduceddiabeticketoacidosisacasereport AT sairaabbas oneyearcourseofolanzapineinduceddiabeticketoacidosisacasereport
_version_	1718439120191094784

One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report

Ejemplares similares